Breaking News Instant updates and real-time market news.

AET

Aetna

$141.36

1.13 (0.81%)

16:51
05/19/17
05/19
16:51
05/19/17
16:51

Aetna sees affirming FY17 adjusted EPS view of $8.80-$9.00, consensus $8.96

According to a regulatory filing, Aetna said that chairman and CEO Mark T. Bertolini and other management will meet with investors and analysts on May 22 before and after a presentation Mr. Bertolini will provide at the UBS Global Healthcare Conference 2017 in New York, New York. During the presentation and meetings, the company expects to reaffirm our full-year 2017 net income per share projection of $4.48 to $4.68 and our full-year 2017 adjusted earnings per share projection of $8.80 to $9.00.

  • 19

    May

AET Aetna
$141.36

1.13 (0.81%)

05/05/17
LEER
05/05/17
NO CHANGE
Target $90
LEER
Outperform
CVS Health should retain Aetna, says Leerink
Leerink analyst David Larsen remains positive on CVS Health (CVS) following the company's earnings call. The analyst believes that as investors look to 2018, CVS will have major headwinds behind it, including volume loss from narrow networks and promotion rationalization in retail. Larsen sees a "significant positive catalyst" in a potential Anthem (ANTM) win later this year, and does not believe there is real risk to the Aetna (AET) business. He reiterates an Outperform rating and $90 price target on CVS' shares.
05/11/17
CLVD
05/11/17
UPGRADE
CLVD
Buy
Aetna upgraded to Buy from Neutral at Cleveland Research
Cleveland Research analyst Steve Willoughby upgraded Aetna (AET) to Buy saying recent research indicates an expanding relationship with CVS likely beginning on January 1, 2018. The analyst believes an enhanced partnership with CVS will generate significant savings for Aetna and support stronger 2018 MA growth, on top of additional earnings growth of 2-7%.
05/15/17
FBCO
05/15/17
NO CHANGE
Target $155
FBCO
Outperform
Aetna price target raised to $155 from $150 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Aetna (AET) to $155 from $150 after the company updated investors on its long-term strategy post the demise of the Humana (HUM) merger. The strategy still includes an intense focus on Medicare Advantage as the key future growth driver, with the company also making it clear that it does not intend to deploy much capital to acquire direct physician and other provider assets. The analyst reiterates an Outperform rating on the shares.
05/15/17
UBSW
05/15/17
NO CHANGE
Target $160
UBSW
Buy
Aetna price target raised to $160 from $147 at UBS
UBS analyst A. J. Rice raised his price target on Aetna to $160 from $147 following its bullish investor update meeting. The company believes long-term earnings will grow in the low double digit range, driven by organic earnings growth and capital deployment, noted Rice, who reiterated his Outperform rating on Aetna shares.

TODAY'S FREE FLY STORIES

UAL

United Continental

$59.71

-8.25 (-12.14%)

08:14
10/20/17
10/20
08:14
10/20/17
08:14
Recommendations
United Continental analyst commentary  »

United Continental lack…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$157.16

0.31 (0.20%)

08:13
10/20/17
10/20
08:13
10/20/17
08:13
Initiation
Stanley Black & Decker initiated  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ENTA

Enanta

$47.40

0.1 (0.21%)

08:09
10/20/17
10/20
08:09
10/20/17
08:09
Hot Stocks
Enanta to present preclinical data on EDP-305 at The Liver Meeting »

Enanta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 06

    Nov

DQ

Daqo New Energy

$32.70

1.01 (3.19%)

08:08
10/20/17
10/20
08:08
10/20/17
08:08
Recommendations
Daqo New Energy analyst commentary  »

Daqo New Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNTX

Gentex

$20.66

0.2 (0.98%)

08:07
10/20/17
10/20
08:07
10/20/17
08:07
Earnings
Gentex reports Q3 EPS 31c, consensus 31c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

GILD

Gilead

$81.59

1.58 (1.97%)

08:06
10/20/17
10/20
08:06
10/20/17
08:06
Hot Stocks
Gilead says study results add to evidence supporting viral hepatitis therapies »

Gilead Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 26

    Oct

  • 06

    Nov

  • 12

    Feb

CELG

Celgene

$135.96

-1.21 (-0.88%)

08:06
10/20/17
10/20
08:06
10/20/17
08:06
Technical Analysis
Technical View: Celgene falls after discontinuing GED-0301 phase III trial »

The stock is down over 6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

PRTA

Prothena

$58.53

-1.83 (-3.03%)

08:05
10/20/17
10/20
08:05
10/20/17
08:05
Conference/Events
Prothena management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 06

    Nov

AUPH

Aurinia Pharmaceuticals

$6.46

-0.05 (-0.77%)

08:05
10/20/17
10/20
08:05
10/20/17
08:05
Hot Stocks
Aurinia Pharmaceuticals to expand retail franchise with novel indications »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$204.62

6.25 (3.15%)

08:04
10/20/17
10/20
08:04
10/20/17
08:04
Recommendations
Ulta Beauty analyst commentary  »

Ulta Beauty weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$7.44

0.1 (1.36%)

08:04
10/20/17
10/20
08:04
10/20/17
08:04
Hot Stocks
Cleveland-Cliffs cuts FYsales, production volume for U.S. iron ore »

Cliffs full-year sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

CAI

CAI International

$31.38

-0.05 (-0.16%)

, TRTN

Triton International

$37.90

-0.24 (-0.63%)

08:04
10/20/17
10/20
08:04
10/20/17
08:04
Recommendations
CAI International, Triton International, Textainer analyst commentary  »

CAI International price…

CAI

CAI International

$31.38

-0.05 (-0.16%)

TRTN

Triton International

$37.90

-0.24 (-0.63%)

TGH

Textainer

$18.40

-0.75 (-3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$351.81

-7.84 (-2.18%)

08:03
10/20/17
10/20
08:03
10/20/17
08:03
Recommendations
Tesla analyst commentary  »

Cowen remains cautious on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

DQ

Daqo New Energy

$32.70

1.01 (3.19%)

08:03
10/20/17
10/20
08:03
10/20/17
08:03
Hot Stocks
Daqo New Energy announces Phase 3B expansion plan for Xinjiang plant »

Daqo New Energy yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMP

Rice Midstream

$20.81

-0.03 (-0.14%)

08:03
10/20/17
10/20
08:03
10/20/17
08:03
Hot Stocks
Rice Midstream raises quarterly distribution 4% to 28.14c per unit »

Rice Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$7.44

0.1 (1.36%)

08:02
10/20/17
10/20
08:02
10/20/17
08:02
Earnings
Cleveland-Cliffs reports Q3 EPS 18c including items, consensus 32c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

HOG

Harley-Davidson

$48.09

0.07 (0.15%)

08:02
10/20/17
10/20
08:02
10/20/17
08:02
Upgrade
Harley-Davidson rating change  »

Harley-Davidson upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$103.78

0.97 (0.94%)

08:02
10/20/17
10/20
08:02
10/20/17
08:02
Earnings
Kansas City Southern reports Q3 adjusted EPS $1.35, consensus $1.31 »

Reports Q3 revenue $657M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

PYPL

PayPal

$67.27

0.02 (0.03%)

08:01
10/20/17
10/20
08:01
10/20/17
08:01
Conference/Events
PayPal management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 22

    Oct

  • 29

    Nov

HBAN

Huntington Bancshares

$13.98

0.03 (0.22%)

08:01
10/20/17
10/20
08:01
10/20/17
08:01
Hot Stocks
Huntington Bancshares raises quarterly dividend 38% to 11c per share »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 15

    Nov

PFPT

Proofpoint

$95.07

1.06 (1.13%)

08:00
10/20/17
10/20
08:00
10/20/17
08:00
Recommendations
Proofpoint analyst commentary  »

Proofpoint initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MU

Micron

$41.31

-0.34 (-0.82%)

08:00
10/20/17
10/20
08:00
10/20/17
08:00
Options
Micron call buyer realizes 50% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

08:00
10/20/17
10/20
08:00
10/20/17
08:00
General news
Fedspeak rounds out the week with Cleveland hawk Mester »

Fedspeak rounds out the…

GOOG

Alphabet

$984.45

-8.36 (-0.84%)

, GOOGL

Alphabet Class A

$1,001.84

-10.9 (-1.08%)

07:59
10/20/17
10/20
07:59
10/20/17
07:59
Periodicals
Google Play launches Instant Apps to try before installation, TNW says »

Google has launched a new…

GOOG

Alphabet

$984.45

-8.36 (-0.84%)

GOOGL

Alphabet Class A

$1,001.84

-10.9 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

KBSTY

Kobe Steel

$3.93

0.22 (5.93%)

07:55
10/20/17
10/20
07:55
10/20/17
07:55
Periodicals
Japan inspects Kobe Steel plant for breach of industrial law, Reuters reports »

The Japan Quality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.